[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637714":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":24,"responsibleParty":41,"collaborators":43,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":24,"enrollmentInfo":57,"targetDuration":24,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":71,"whyStopped":24,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":24},{"fullName":5,"class":6},"University of Sunderland","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","Participants in this arm will attend a two-hour community workshop designed to encourage informed help-seeking and engagement with prostate cancer health checks and PSA testing.",[13],"Other: The intervention is a two-hour workshop that includes multiple components to encourage Black men to request prostate cancer diagnosis tests.",{"label":15,"type":6,"description":16,"interventionNames":17},"Control","Participants in this arm will be placed on a waiting list and will be invited to attend the workshop after the 6-month follow-up period.",[18],"Other: Waitlist",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"The intervention is a two-hour workshop that includes multiple components to encourage Black men to request prostate cancer diagnosis tests.","The intervention was co-designed in partnership with 13 Black men to address barriers and facilitators to early diagnosis of prostate cancer among Black men. The workshop includes multiple components, including peer-led discussions on barriers to early diagnosis, health education delivered by a Black GP, activities aimed at supporting effective communication with GPs and reception staff, and video testimonials from prostate cancer survivors, women, and religious leaders.",[9],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"Waitlist","Participants in the control group will be placed on a waitlist to receive the intervention after six months",[15],[30],{"name":31,"affiliation":5,"role":32},"Floor Christie-de Jong","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":24,"email":37},"CONTACT","0044 191 5153445","Floor.Christie-DeJong@sunderland.ac.uk",{"name":39,"role":35,"phone":24,"phoneExt":24,"email":40},"Rawand Jarrar","rawand.jarrar@sunderland.ac.uk",{"type":32,"investigatorFullName":31,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Associate Professor in Public Health for Medicine",[44],{"name":45,"class":6},"University of Glasgow","100637714","early-diagnosis-of-prostate-cancer-for-black-men-100637714",false,"NCT07620717","Early Diagnosis of PROstate CANcer for Black Men","Encouraging Early Diagnosis of PROstate CANcer for Black Men (the PROCAN-B+ Study): A Mixed-Methods, Two-Arm, Multi-Centre Randomised Controlled Trial of a Co-Produced, Peer-Led Intervention","PROCAN-B+","Inclusion Criteria:\n\n* Black men aged 45 years or over, living in North East England, North Yorkshire, London or Scotland\n\nExclusion Criteria:\n\n* Men from other ethnicities\n* Black men aged less than 45 years\n* Black men with previous prostate cancer diagnosis",true,"MALE","45 Years",{"count":58,"type":59},300,"ESTIMATED","INTERVENTIONAL",[62],"NA","PROCAN-B+ is a mixed-methods, two-arm, multi-centre randomised controlled trial evaluating a co-designed, peer-led intervention to encourage informed help-seeking and engagement with prostate cancer health checks and Prostate Specific Antigen (PSA) testing among Black men aged 45 years and over with no history of prostate cancer.\n\nThe study will recruit 300 participants across three UK sites: North East England including Leeds, Scotland, and London. Following eligibility screening and baseline data collection, participants will be individually randomised in a 1:1 ratio to either the intervention or wait-list control arm by an independent clinical trials unit. Participants allocated to the intervention arm will attend a two-hour co-designed community-based workshop shortly after randomisation, while participants allocated to the control arm will be invited to attend the workshop following the 6-month follow-up period. Due to the nature of the intervention, participants and researchers will not be blinded to allocation.\n\nThe intervention was co-designed in partnership with Black men and includes peer-led discussions on barriers to early diagnosis of prostate cancer, health education delivered by a Black GP, activities aimed at supporting effective communication with healthcare professionals, and video testimonials from prostate cancer survivors, women, and religious leaders.\n\nPrimary outcomes include self-reported discussions with GPs relating to prostate cancer risk, self-reported PSA testing, and GP-recorded PSA testing where participant consent is provided. Secondary outcomes include knowledge of prostate cancer, attitudes towards prostate cancer health checks and PSA testing, and help-seeking behaviours. Data will be collected at baseline, 3-month, and 6-month follow-up.\n\nA qualitative process evaluation involving participants, peer facilitators, and professionals will explore experiences and acceptability of the intervention and inform future implementation and scale-up.",[65],"Prostate Cancer (Diagnosis)",[67,68,69,70],"Prostate Cancer","Early diagnosis","Black men","Participatory research","NOT_YET_RECRUITING","2026-05-26",{"date":74,"type":75},"2026-06-02","ACTUAL",{"date":77,"type":59},"2026-06-01",{"date":79,"type":59},"2028-08-31",{"name":5,"class":6}]